Welcome to the all-new Vetlearn

  • Vetlearn is becoming part of NAVC VetFolio.
    Starting in January 2015, Compendium and
    Veterinary Technician articles will be available on
    NAVC VetFolio. VetFolio subscribers will have
    access to not only the journals, but also:
  • Over 500 hours of CE
  • Community forums to discuss tough cases
    and networking with your peers
  • Three years of select NAVC Conference
    Proceedings
  • Free webinars for the entire healthcare team

To access Vetlearn, you must first sign in or register.

registernow

  Sign up now for:
Become a Member

Compendium July 2008 (Vol 30, No 7)

Dirofilaria immitis in Cats: Diagnosis and Management

by C. Thomas Nelson, DVM

    CETEST This course is approved for 2.0 CE credits

    Start Test

    Abstract

    Imaging and laboratory studies can help with the diagnosis of heartworm disease in cats, but no test is definitive. Furthermore, even when the diagnosis can be reliably established, therapy directed at the heartworms does little to help the cat. Rather, management is directed at alleviating clinical signs, with an emphasis on prevention for all.

    Diagnosis is the most challenging part of feline heartworm disease because no single test can reliably detect heartworms at all stages. Veterinarians must be will­ing to conduct multiple and even repeat tests (Table 1 and Figure 1) to obtain a diagnosis and to correctly interpret and apply the results.b

    Diagnosis

    Microfilariae

    Filtration tests for microfilariae are virtually useless in cats because cats are only transiently microfilaremic, if at all. To be microfilaremic, a cat must have both a mature male and a mature female worm, and because cats typically only have one or two worms, the infections are often single sex. When microfilariae are produced, they are only present for 1 or 2 months, at which time the cat's immune system eliminates them and suppresses further embryogenesis.1

    Radiology

    The most common radiographic finding in feline heartworm disease is an enlargement of the right caudal lobar artery (see  Figure 2 in the companion article). This is best seen on a ventrodorsal view. A bronchointerstitial pulmonary pattern (Figure 2) may also be noted, but this finding is not unique to feline heartworm disease.

    The use of radiology has limitations, as only 55% of heartworm antigen−positive cats had radiographic signs consistent with heartworm disease in one study.2 Follow-up on some of these cats showed improvement in radiographic scores in 50% of cases and worsened scores in 16%. Because cats can tolerate adult worm infections fairly well and it is common for clinical signs to either resolve or become intermittent, such results are to be expected.

    Echocardiography

    In skillful hands, ultrasonography has been shown to detect 100% of adult feline heartworm infections, but the technician must be able to follow the caudal pulmonary arteries to their bifurcation within the lung fields.3 Other reports cite echocardiography as detecting 68% of natural infections4 and 88% of experimental infections in cats.5

    The cuticle of the adult heartworm is strongly echogenic, producing short, segmented, parallel lines where the imaging plane crosses the worm. Heartworm signatures on echocardiography have been described as equal signs (=;Figure 3). However, the imaging beam may cross the same worm multiple times, making quantifying the number of worms difficult.

    Serology

    There is an ongoing debate about the accuracy of antigen and antibody testing for feline heartworm disease. Both tests can provide valuable information, but a thorough understanding of their limitations is essential to interpreting results correctly.

    Antigen tests are considered the gold standard in diagnosing heartworms in dogs. However, they do not detect early or male-only worm infections. Part of the disease process in cats is the death of juvenile worms at 3 to 4 months postinfection, which antigen tests cannot detect. Again, because most infected cats have one or, at most, two adult worms, single-sex, male-only infections are common.1 Multiple studies have reported the sensitivity of antigen testing in mature heartworm infections in cats to be 50% to 86%.6-9 As a result, a negative antigen test result does not rule out heartworm infection in cats.

    The antibody test was initially very promising. In experimental studies, it detected 93% to 100% of heartworm infections, including late L4 larvae as well as juvenile and adult worms.7,10,11 However, a significant number of cats with adult heartworms are antibody negative. For example, in a retrospective study of 50 cats with known heartworm disease, there was a 14% false-negative rate.12 Most of the cats in the study (72%) had clinical signs indicating active disease.

    A necropsy study of shelter cats in Texas6 reported a 50% false-negative rate for one antibody test, and a similar study in Florida had an 11% to 68% false-negative rate on eight different antibody tests.8 Twenty-one of 31 cats with heartworm disease had a negative result on at least one of the eight antibody tests evaluated. All of these studies have drawbacks, but collectively they demonstrate that a negative antibody test result cannot be used to rule out heartworm infection.

    The use of antigen and antibody tests must be tempered by an awareness of these limitations. It is difficult to establish a diagnosis with a single method unless the antigen test result is positive or a worm is detected on ultrasonography. Diagnosis generally requires multiple tests. If antibody or antigen testing is used for initial screening, the practitioner should be prepared to conduct additional tests if the results do not support the clinical suspicions. This is illustrated by the results of a study of 22 heartworm-infected cats in which thoracic radiography, echocardiography, and antigen and antibody tests were conducted. Pulmonary enlargement was seen in 64% of the cats, worms were visualized by echocardiography in 64%, 55% were antigen positive, and 82% were antibody positive.13 In a multicenter study of 215 cats in which clinical signs were correlated to serology and radiographic findings, 44% of the cats that presented with coughing or dyspnea and intermittent vomiting unrelated to eating were antibody positive.14 This was twice the antibody base rate for the area. Of the cats with radiographic signs consistent with heartworm disease, 60% were antibody positive.

    Implications

    Because heartworm disease in cats is primarily caused by juvenile worms, antibody serology data can be used to estimate the percentage of cats infected at some point in their life span, thus establishing regional risk. In 1997, 15.9% of the 25,277 cats tested at Heska's reference laboratory were antibody positive.15 A second study mainly conducted in the Northeastern and Midwestern states reported a 12% antibody-positive rate.16 Analysis of data from IDEXX reference laboratories shows the national rates of feline heartworm antigen, FeLV, and FIV detection to be 1%, 1.9%, and 1%, respectively, indicating that heartworm disease is a significant health risk in cats.17 As a result, IDEXX is adding a heartworm antigen spot to its point-of-care test for FeLV and FIV. This new format should increase the number of cats tested yearly for heartworms from tens of thousands to millions. It is important for practitioners to understand that they will be testing for the presence of the adult female worm. Although all cats with adult worms have heartworm-associated respiratory disease (HARD), not all cats with HARD have adult worms. The clinical signs associated with most cases of HARD are the result of juvenile worm infections and are not detected by antigen testing. Nonetheless, it is likely that, in the first year of the new test's availability, more than 25,000 cats will be diagnosed with adult heartworm infections that previously would not have been detected.

    What are the implications of increased testing? In addition to the "rude awakening" in store for veterinarians and cat owners who did not believe heartworms existed in cats in their area, it should provide more information about cats at risk for HARD.

    The 1% heartworm antigen-positive rate will probably emerge as just the "tip of the iceberg" (Figure 4) of cats with or at risk for HARD because only cats with adult female heartworms test positive for antigen. Also, a significant number of cats infected with heartworms at any stage are missed due to the limitations of current testing modalities. Although the nationwide antibody-positive rate is 16%, 50% of cats with known HARD lesions (including 25% to 30% of cats with adult heartworms6,8) are antibody negative 8 months after infection.18 Based on these numbers, it could be argued that the percentage of cats at risk for HARD in a given area is twice the base antibody rate (32%). At the same time, Browne et al19 have showed that half of antibody-positive cats (50% of 16% = 8%) have lung lesions consistent with HARD. If, at a conservative estimate, an additional 2% of cats that are negative on all tests have HARD, there may be as many as 10 cats with HARD for every one cat identified as having adult heartworms. Given that the adult heartworm infection rate in cats is 10% of the rate in unprotected dogs and that for every cat with an adult infection there may be 10 cats with HARD from juvenile infections, it is possible that cats are infected at the same rate as dogs.

    Treatment

    Because no form of medical adulticidal therapy has been shown to increase the survival rate of cats harboring adult heartworms, treatment is aimed at controlling clinical signs. On diagnosis, thoracic radiographs should be obtained or reviewed to look for any evidence of vascular, bronchointerstitial, or parenchymal disease. Cats exhibiting clinical or radiographic signs of disease should be given antiinflammatory doses of glucocorticosteroids (prednisone, 1 to 2 mg/kg/day), reduced weekly over a 3- to 4-week period. If clinical signs recur or persist, alternate-day glucocorticosteroids should be given at the lowest effective dose. Radiography and serology are then repeated every 6 months to monitor the course of the disease. A monthly heartworm prevention regimen should be initiated for all cats; because microfilaremia is typically rare or marginal in cats (unlike dogs), it is safe to administer preventive agents to heartworm-positive cats.

    Cats presenting in acute respiratory distress should be given oxygen, "shock" doses of glucocorticosteroids (dexamethasone sodium phosphate, 1 to 2 mg/kg IM or IV, or prednisolone sodium succinate, 50 to 100 mg/kg/cat IV), and a bronchodilator (e.g., aminophylline, 6.6 mg/kg IV). Supportive therapy (IV fluids and thermal support) is maintained until the cat's condition is stabilized. Retrospective studies indicate that 10% to 20% of cats with adult heartworm infections die as a result of complications from a dead or dying heartworm.20 Owners of cats with an adult heartworm infection diagnosed either by antigen testing or echocardiography should be informed about this risk and instructed to seek prompt medical attention at any sign of respiratory distress. It may be prudent to give the owner a syringe containing 10 mg of dexamethasone sodium phosphate with instructions to administer in the event of a respiratory crisis to initiate treatment, but it must be emphasized that this does not eliminate the need for emergency veterinary care.

    There is anecdotal evidence that antileukotrienes (e.g., montelukast, 2 mg/day) may help to thwart an acute, fatal lung injury when an adult worm dies. Dillon21 has been using this approach for more than 6 years, and no cat so treated has yet presented in acute respiratory distress. There is also interest in the use of doxycycline in heartworm-positive cats. Heartworms harbor an intracellular endosymbiont of the genus Wolbachia, which is found in many of the filarial nematodes that cause disease in humans and animals (including Onchocerca volvulus, Wuchereria bancrofti, Brugia malayi, and Dirofilaria immitis). Doxycycline is now being used to treat some filarial nematode infections in humans.22,23 Studies indicate that pretreating a dog with doxycycline before administering adulticidal medication reduces the pathology associated with worm death,24 but similar studies have not yet been completed in cats.

    Prevention

    All indoor and outdoor cats in endemic areas should receive heartworm prevention because the risk for indoor cats has been shown to be similar to that for outdoor cats.12,14,16 There are four products on the market labeled for cats that are safe and virtually 100% effective in preventing heartworm infection. Ivermectin is available as a chewable treat, milbemycin as a flavored tablet, and selamectin and moxidectin as topical applications. Spectra vary among products, but all control multiple parasites in addition to heartworms.

    Conclusion

    Although the promise of universal heartworm antigen testing in cats will not translate into universal detection, the concept of monthly prevention in all cats should be readily understandable to owners. With veterinarians leading the way in public education, preventive measures for cats may soon be as acceptable as they currently are for dogs.

    A companion article on prevalence and pathophysiology begins here.

    Downloadable PDF

    Dr. Nelson discloses that he has received financial support from the American Heartworm Society, the Companion Animal Parasite Council, IDEXX Laboratories, Fort Dodge Animal Health, the KNOW Heartworms campaign, Merial, and Pfizer Animal Health.

    1. McCall JW, Dzimianski MT, McTier TL, et al. Biology of experimental heartworm infection in cats. In: Soll MD, ed. Proceedings of the Heartworm Symposium '92. Batavia, IL: American Heartworm Society; 1992:71-79.

    2. Brawner WR, Dillon AR, Robertson-Plough CK, Guerrero J. Radiographic diagnosis of feline heartworm disease and correlation to other clinical criteria: results of a multicenter clinical case study. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society; 1998:91-95.

    3. Venco L, Morini S, Ferrari E, Genchi C. Technique for identifying heartworms in cats by 2-D echocardiography. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society; 1998:97-102.

    4. Defrancesco TC, Atkins CE. The utility of echocardiography in the diagnosis of feline heartworm disease: a review of published reports. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society; 1998:103-105.

    5. Atkins CE, Arther RG, Ciszewski DK, et al. Echocardiographic quantification of Dirofilaria immitis in experimentally-infected cats. Vet Parasitol 2008. Accepted for publication.

    6. Nelson CT, Self TS. Incidence of Dirofilaria immitis in shelter cats in southeast Texas. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society, 1998:63-66.

    7. McCall JW, Guerrero J, Supakorndej P, et al. Evaluation of the accuracy of heartworm antigen and antibody test for cats. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society; 1998:127-134.

    8. Snyder PS, Levy JK, Salute ME, et al. Performance of serologic tests used to detect heartworm infection in cats. JAVMA 2000;216:693-700.

    9. Berdoulay P, Levy JK, Snyder PS, et al. Comparison of serological tests for the detection of natural heartworm infection in cats. JAAHA 2004;40:376-384.

    10. Bestul KJ, McCall JW, Nonglak S, et al. Evaluation of the Assure FH antibody assay for the detection of feline heartworm infection. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society; 1998:179-186.

    11. Donoghue AR, Mondesire RR, Porter JP. Detection of antibodies to Dirofilaria immitis in the cat using a highly specific recombinant antigen. Presented at the North American Veterinary Conference, Orlando, FL, January 11-15, 1997.

    12. Atkins CE, DeFrancesco TC, Coats JR, et al. Heartworm infection in cats: 50 cases (1985-1997). JAVMA 2000;217:355-358.

    13. DeFrancesco TC, Atkins CE, Miller MW, et al. Use of echocardiography for the diagnosis of heartworm disease in cats: 43 cases (1985-1997) JAVMA 2001;218(1):66-69.

    14. Dillon AR, Brawner WR, Robertson-Plough CK, Guerrero J. Feline heartworm disease: correlation of clinical signs, serology, and other diagnostics. Results of a multicenter study. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society; 1998:153-158.

    15. Piche' CA, Cavanaugh MT, Donoghue AR, Radecki SV. Results of antibody and antigen testing for feline heartworm infection at Heska® veterinary diagnostic laboratories. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society; 1998:139-143.

    16. Miller MW, Atkins CE, Stemme K, et al. Prevalence of exposure to Dirofilaria immitis in multiple areas of the United States. In: Seward RL, ed. Recent Advances in Heartworm Disease: Symposium '98. Batavia, IL: American Heartworm Society; 1998:161-166.

    17. Lorentzen L, Caoloa A. Incidence of positive heartworm antibody and antigen tests at IDEXX Laboratories: trends and potential impact on feline heartworm awareness and prevention. Vet Parasitol 2008. Accepted for publication.

    18. Dillon AR, Blagburn BL, Tilson DM, et al. Immature heartworm infection produces pulmonary parenchymal, airway, and vascular disease in cats. Presented at the 12th Triennial Heartworm Symposium, Washington, DC, July 2007.

    19. Browne LE, Carter TD, Levy JK, et al. Pulmonary arterial disease in cats seropositive for Dirofilaria immitis but lacking adult heartworms in the heart and lungs. Am J Vet Res 2005;66:1544-1549.

    20. Genchi C, Venco L, Ferrari N, et al. Feline heartworm (Dirofilaria immitis) infection: a statistical elaboration of the duration of the infection and life expectancy in asymptomatic cats. Vet Parasitol 2008. Accepted for publication.

    21. Heartworm-Associated Respiratory Disease in Cats. Pfizer Animal Health; 2007. Accessed May 2008 at http://www.advanstarvhc.com/c9.

    22. Hoerauf A, Mand S, Adjei O, et al. Depletion of Wolbachia in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 2001;357:1415-1416.

    23. Taylor MJ, Bandi C, Hoerauf AM, Lazdins J. Wolbachia bacteria of filarial nematodes: a target for control? Parasitol Today 2000;16:179-180.

    24. McCall JW, Genchi C, Kramer L, et al. Heartworm and Wolbachia: therapeutic implications. Vet Parasitol 2008. Accepted for publication.

    For the complete American Heartworm Society 2007 Guidelines for the Diagnosis, Prevention and Management of Heartworm (Dirofilaria immitis) Infection in Cats, please visit www.heartwormsociety.org.

    References »

    NEXT: Editorial — Human Behavior and Animal Welfare

    CETEST This course is approved for 2.0 CE credits

    Start Test

    didyouknow

    Did you know... Most tick-borne pathogens of mammals are transmitted by hard ticks, although a couple of soft tick species are also of medical interest.Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More
    Subscribe